Matches in Nanopublications for { ?s ?p "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP702860.RARJhxPjsJEZ0dEWTU_p8ULUGXlXUUYKFBEMineMhlZpI130_assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702860.RARJhxPjsJEZ0dEWTU_p8ULUGXlXUUYKFBEMineMhlZpI130_provenance.
- NP761661.RAQW3xZ3bAIMaBnWLyuuN19J5efM8bVmatHevwp0joiug130_assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761661.RAQW3xZ3bAIMaBnWLyuuN19J5efM8bVmatHevwp0joiug130_provenance.
- NP784274.RAjIVoyG27BUQkn6-QmnF-PN6m6IdJq0AubZ14DiiBsfQ130_assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784274.RAjIVoyG27BUQkn6-QmnF-PN6m6IdJq0AubZ14DiiBsfQ130_provenance.
- NP898462.RAAwUbVBrBFtU58C8ndcDHst76tD7SekSVp4V1A76kwi8130_assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898462.RAAwUbVBrBFtU58C8ndcDHst76tD7SekSVp4V1A76kwi8130_provenance.
- NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_provenance.
- NP351807.RAUvOGdQRMC0nqsRq82hnCeB1F5gxyLdR8cKDNjsEkyY8130_assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351807.RAUvOGdQRMC0nqsRq82hnCeB1F5gxyLdR8cKDNjsEkyY8130_provenance.
- assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP898464.RA5vlYMTEo4jBDjdW4fOLVLimTTvAzaj-VYHdETTxQjYM130_assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898464.RA5vlYMTEo4jBDjdW4fOLVLimTTvAzaj-VYHdETTxQjYM130_provenance.
- NP898466.RAS51rE9wowb9a5xLmhXqSSnfXtA-X-J2bLTGkUGLNz14130_assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898466.RAS51rE9wowb9a5xLmhXqSSnfXtA-X-J2bLTGkUGLNz14130_provenance.
- NP352108.RApzdzfC5pVcVwK6hD3t9S8RtzVlKEWUyPiO_p2B2h0Z0130_assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352108.RApzdzfC5pVcVwK6hD3t9S8RtzVlKEWUyPiO_p2B2h0Z0130_provenance.